VWM
TXG icon

Venturi Wealth Management’s 10x Genomics TXG Stock Holding History

Venturi Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$916K Sell
23,889
-2,134
-8% -$55.9K 0.04% 241
2026
Q1 		$552K Buy
26,023
+82
+0.3% +$1.64K 0.02% 324
2025
Q4 		$423K Buy
25,941
+2,998
+13% +$45.3K 0.02% 386
2025
Q3 		$268K Buy
22,943
+4,984
+28% +$65K 0.01% 467
2025
Q2 		$208K Buy
+17,959
New +$164K 0.01% 513
2025
Q1 		– Sell
-1,124
Closed -$16.1K – 1736
2024
Q4 		$16.1K Sell
1,124
-1,318
-54% -$20.8K ﹤0.01% 1315
2024
Q3 		$55.1K Buy
2,442
+2,240
+1,109% +$46.3K ﹤0.01% 735
2024
Q2 		$3.93K Buy
202
+31
+18% +$812 ﹤0.01% 1271
2024
Q1 		$6.42K Sell
171
-48
-22% -$2.11K ﹤0.01% 1027
2023
Q4 		$12.3K Buy
219
+43
+24% +$1.87K ﹤0.01% 827
2023
Q3 		$7.26K Buy
+176
New +$9.16K ﹤0.01% 867

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Venturi Wealth Management's TXG Position: Q2 2026 in Review

Venturi Wealth Management reduced its 10x Genomics (TXG) stake by 8.2% in Q2 2026, selling an estimated $55.9K and leaving 23,889 shares worth $916K. The position accounts for 0.04% of the portfolio, ranked #241.

Venturi Wealth Management first reported a position in TXG in Q3 2023 and has held it in 11 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Venturi Wealth Management held 23,889 shares of 10x Genomics worth $916K as of Q2 2026.
  • Venturi Wealth Management sold 2,134 10x Genomics shares in Q2 2026, an estimated $55.9K.
  • 10x Genomics made up 0.04% of Venturi Wealth Management's portfolio in Q2 2026, its #241 holding.
  • Venturi Wealth Management first reported a position in 10x Genomics in Q3 2023 and has held it in 11 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.